Express Scripts will include Cyltezo and both Sandoz products (Hyrimoz and unbranded adalimumab-adaz) – inflammatory disease biosimilars with competitive net costs – as preferred products on the ...

Express Scripts has determined that it will list INPEFA as a preferred product on Medicare national formularies on November 1, 2023 THE WOODLANDS, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Lexicon ...

The FTC's landmark settlement forces Express Scripts PBM to overhaul practices, banning the preference of expensive insulin ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal Trade Commission. February 4, 2026. Accessed February 5, 2026.

Oct 29 (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said it may quickly change its preferred drug formulary to favor an expected new hepatitis C drug from AbbVie if it is clinically ...

Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Meters and Test Strips on the Express Scripts Commercial National Preferred Formulary Providing accurate and ...

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.